Chia, S., Bedard, P. L., Hilton, J., Amir, E., Gelmon, K., Goodwin, R., . . . Seymour, L. (2019). A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229). Oncologist.
Styl cytowania ChicagoChia, Stephen, et al. "A Phase Ib Trial of Durvalumab in Combination With Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229)." Oncologist 2019.
Styl cytowania MLAChia, Stephen, et al. "A Phase Ib Trial of Durvalumab in Combination With Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229)." Oncologist 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..